270 related articles for article (PubMed ID: 32880874)
21. 2-Amino-1,3,4-thiadiazole as a potential scaffold for promising antimicrobial agents.
Serban G; Stanasel O; Serban E; Bota S
Drug Des Devel Ther; 2018; 12():1545-1566. PubMed ID: 29910602
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and anticancer activity of novel pyrimidine and pyrimidine-thiadiazole hybrid glycosides.
Khalaf HS; Tolan HEM; Radwan MAA; Mohamed AM; Awad HM; El-Sayed WA
Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):1036-1056. PubMed ID: 32312171
[TBL] [Abstract][Full Text] [Related]
23. One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles.
Kumar D; Vaddula BR; Chang KH; Shah K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2320-3. PubMed ID: 21429743
[TBL] [Abstract][Full Text] [Related]
24. Biological activity of oxadiazole and thiadiazole derivatives.
Atmaram UA; Roopan SM
Appl Microbiol Biotechnol; 2022 May; 106(9-10):3489-3505. PubMed ID: 35562490
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives.
Zhao HC; Shi YP; Liu YM; Li CW; Xuan LN; Wang P; Zhang K; Chen BQ
Bioorg Med Chem Lett; 2013 Dec; 23(24):6577-9. PubMed ID: 24239016
[TBL] [Abstract][Full Text] [Related]
26. Thiadiazole - A promising structure in design and development of anti-Alzheimer agents.
Hatami M; Basri Z; Sakhvidi BK; Mortazavi M
Int Immunopharmacol; 2023 May; 118():110027. PubMed ID: 37011500
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models.
Finlay MRV; Anderton M; Bailey A; Boyd S; Brookfield J; Cairnduff C; Charles M; Cheasty A; Critchlow SE; Culshaw J; Ekwuru T; Hollingsworth I; Jones N; Leroux F; Littleson M; McCarron H; McKelvie J; Mooney L; Nissink JWM; Perkins D; Powell S; Quesada MJ; Raubo P; Sabin V; Smith J; Smith PD; Stark A; Ting A; Wang P; Wilson Z; Winter-Holt JJ; Wood JM; Wrigley GL; Yu G; Zhang P
J Med Chem; 2019 Jul; 62(14):6540-6560. PubMed ID: 31199640
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents.
Sun J; Yang YS; Li W; Zhang YB; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem Lett; 2011 Oct; 21(20):6116-21. PubMed ID: 21889345
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
Kumar S; Gopalakrishnan V; Hegde M; Rana V; Dhepe SS; Ramareddy SA; Leoni A; Locatelli A; Morigi R; Rambaldi M; Srivastava M; Raghavan SC; Karki SS
Bioorg Med Chem Lett; 2014 Oct; 24(19):4682-4688. PubMed ID: 25205189
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents.
Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P
Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of antiproliferative effect in vitro of some 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole derivatives.
Matysiak J
Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):988-91. PubMed ID: 16819217
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents.
Altıntop MD; Sever B; Özdemir A; Ilgın S; Atlı Ö; Turan-Zitouni G; Kaplancıklı ZA
Anticancer Agents Med Chem; 2018; 18(11):1606-1616. PubMed ID: 29745341
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents.
Ibrahim DA
Eur J Med Chem; 2009 Jul; 44(7):2776-81. PubMed ID: 19203813
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives).
Hayat F; Salahuddin A; Zargan J; Azam A
Eur J Med Chem; 2010 Dec; 45(12):6127-34. PubMed ID: 20961670
[TBL] [Abstract][Full Text] [Related]
35. 1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold.
Haider S; Alam MS; Hamid H
Eur J Med Chem; 2015 Mar; 92():156-77. PubMed ID: 25553540
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic Properties of 1,3,4-Thiadiazole Derivatives-A Review.
Janowska S; Paneth A; Wujec M
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962192
[TBL] [Abstract][Full Text] [Related]
37. 1,3,4-thiadiazole: a privileged scaffold for drug design and development.
Han X; Yu YL; Hu YS; Liu XH
Curr Top Med Chem; 2021; 21(28):2546-2573. PubMed ID: 34766891
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro antiproliferative evaluation of novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone.
Jing F; Fu X; Li S; Li B; Zhao J; Wang X; Liu Y; Chen B
Chem Pharm Bull (Tokyo); 2015; 63(6):431-7. PubMed ID: 26027467
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological assessment of ciprofloxacin-derived 1,3,4-thiadiazoles as anticancer agents.
Ahadi H; Shokrzadeh M; Hosseini-Khah Z; Ghassemi Barghi N; Ghasemian M; Emadi E; Zargari M; Razzaghi-Asl N; Emami S
Bioorg Chem; 2020 Dec; 105():104383. PubMed ID: 33130342
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
